Based on the above finding that PPP2R1B suppresses CRC metastasis through the dephosphorylation of p-ERK, we investigated whether the combination of PPP2R1B and p-ERK could be used to predict CRC survival better than either protein alone. The gene discussed is PPP2R1B; the disease is colorectal carcinoma.